[AACR] Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma

happycurio Post time 2024-1-30 13:56:41 | Show all posts |Read mode
Reward30points

journal£ºMolecular Cancer Therapeutics

Authors£ºWenjuan Zhang; Rachael A. Vaubel; Ju-Hee Oh; Ann C. Mladek; Surabhi Talele; Wenqiu Zhang; Katie L. Waller; Danielle M. Burgenske; Jann N. Sarkaria; William F. Elmquist

Published date£º2024-1-3

DOI£º10.1158/1535-7163.mct-23-0217

PDF link£ºhttps://aacrjournals.org/mct/art ... 544/mct-23-0217.pdf

Article link£ºhttp://dx.doi.org/10.1158/1535-7163.mct-23-0217

Article Source£ºAmerican Association for Cancer Research (AACR)¡£


Remark£º

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
trungduong2012 Post time 2024-1-30 13:56:42 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    880

Latest Reply

Return to the list